BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1676563)

  • 1. Natural course of Graves' disease after subtotal thyroidectomy and management of patients with postoperative thyroid dysfunction.
    Kuma K; Matsuzuka F; Kobayashi A; Hirai K; Fukata S; Tamai H; Miyauci A; Sugawara M
    Am J Med Sci; 1991 Jul; 302(1):8-12. PubMed ID: 1676563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.
    Mori Y; Matoba N; Miura S; Sakai N; Taira Y
    World J Surg; 1992; 16(4):647-52; discussion 652-3. PubMed ID: 1357830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative changes in thyrotropin-binding inhibitory immunoglobulin level in patients with Graves' disease: is subtotal thyroidectomy a suitable therapeutic option for patients of childbearing age with Graves' disease?
    Sugino K; Ito K; Ozaki O; Mimura T; Iwasaki H; Wada N
    World J Surg; 1999 Jul; 23(7):727-31. PubMed ID: 10390595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in thyroid function and immunological parameters long after subtotal thyroidectomy for Graves' disease.
    Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Asanuma K; Hama Y; Ito K; Maruyama M; Amano J
    Eur J Surg; 1998 Mar; 164(3):173-8. PubMed ID: 9562276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of prognostic factors affecting the thyroid functional status after subtotal thyroidectomy for Graves' disease.
    Okamoto T; Fujimoto Y; Obara T; Ito Y; Aiba M
    World J Surg; 1992; 16(4):690-5; discussion 695-6. PubMed ID: 1413838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in thyrotropin receptor antibody after subtotal thyroidectomy in Graves' disease: comparison with the degree of lymphocytic infiltration in the thyroid.
    Cho BY; Oh SK; Shong YK; Kim SE; Yoo HY; Lee HK; Koh CS; Min HK
    Autoimmunity; 1990; 8(2):143-7. PubMed ID: 1983330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up evaluation of patients with Graves' disease treated by subtotal thyroidectomy and risk factor analysis for post-operative thyroid dysfunction.
    Sugino K; Mimura T; Toshima K; Iwabuchi H; Kitamura Y; Kawano M; Ozaki O; Ito K
    J Endocrinol Invest; 1993 Mar; 16(3):195-9. PubMed ID: 8099920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting thyroid function after subtotal thyroidectomy for Graves' disease: case control study by remnant-weight matched-pair analysis.
    Ozaki O; Ito K; Mimura T; Sugino K; Ito K
    Thyroid; 1997 Aug; 7(4):555-9. PubMed ID: 9292942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
    Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
    Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the thyroid function of Graves' disease patients treated by subtotal thyroidectomy.
    Sugino K; Ito K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Yano Y; Uruno T; Akaishi J; Suzuki A; Masaki C; Ito K
    Endocr J; 2012; 59(12):1115-20. PubMed ID: 22971989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperthyroidism with potent thyroid-stimulation-blocking antibodies and negative thyroid-stimulating antibodies after subtotal thyroidectomy for Graves' disease with follicular thyroid carcinoma.
    Sugimoto M; Nakamura S; Hattori J; Yamada T; Horiya Y; Hara S; Shima H
    Intern Med; 1993 Mar; 32(3):266-8. PubMed ID: 8101110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term triiodothyronine in prevention of temporary hypothyroidism after subtotal thyroidectomy for Graves' disease.
    Wilkin TJ; Gunn A; Isles TE; Crooks J; Beck JS
    Lancet; 1979 Jul; 2(8133):63-6. PubMed ID: 87965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative change of thyroid stimulating hormone receptor antibody level: possible marker for predicting recurrent hyperthyroidism in patients with Graves' disease after subtotal thyroidectomy.
    Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
    World J Surg; 1996 Sep; 20(7):801-6; discussion 806-7. PubMed ID: 8678954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of subtotal thyroidectomy with propranolol preparation on antibody activity in Graves' disease.
    Steel NR; Taylor JJ; Young ET; Farndon JR; Holcombe M; Kendall-Taylor P
    Clin Endocrinol (Oxf); 1987 Jan; 26(1):97-106. PubMed ID: 3802553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.